Fidia S.p.A. (BIT: FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 1.62M |
| Revenue (ttm) | 29.17M |
| Net Income (ttm) | -6.44M |
| Shares Out | 31.09M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 400,283 |
| Open | 0.0512 |
| Previous Close | 0.0520 |
| Day's Range | 0.0482 - 0.0512 |
| 52-Week Range | 0.0482 - 1.2950 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2024 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
Financial StatementsNews
Notes on chocolate: wintery flavours of pine and mint
Freeze-dried pine needles bring back memories of the great outdoors Becky, a local friend, recently texted me in great excitement. She had been given (or may have stolen, I didn’t ask too many questio...
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
HHS houses major health agencies in the U.S., like the FDA, the CDC and the NIH, and it's also responsible for Medicare and Medicaid.
Syndax wins FDA approval for leukemia drug revumenib
Syndax Pharmaceuticals' Revuforj (revumenib) approved by FDA for relapsed acute leukemia with KMT2A gene translocation. Read more here.
Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
– Approval based on positive data from the AUGMENT-101 clinical trial, in which Revuforj delivered robust and durable rates of remission in R/R acute leukemia patients with a KMT2A translocation – – S...
Moderna Shares Are Dipping Today: What's Going On?
Shares of Moderna Inc . (NASDAQ: MRNA) are trading lower after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Here’s what you need t...
How controversial is Trump’s pick of RFK Jr as US health secretary?
More about Robert F Kennedy Jr, Trump's health secretary pick who is sceptical of vaccines, the FDA and fluoride.
Even if RFK Jr. fires everyone at the FDA, if won’t matter because he doesn’t know anyone with the ‘technical expertise’ to alter the rules, former chief counsel says
Donald Trump has tapped vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Some large European and U.S. vaccine maker stocks have fallen in reaction to Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services . Kennedy has been known to be again...
Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous
Federal employees are concerned over President-elect Donald Trump’s pick, Robert F. Kennedy Jr. , to lead the Department of Health and Human Services . What Happened : Employees within the U.S. Food a...
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay or distract viewers from risk information.
New Study Charts Adverse Events In Psychedelic-Assisted Therapies
As interest in psychedelic-assisted therapies (PATs) grows, so does the need for clearer safety guidelines. Psychedelic treatments using substances like psilocybin , LSD , and MDMA are being explored ...
Vaccine makers close lower amid reports RFK Jr may head HHS
Vaccine maker shares closed lower Thursday amid reports that Donald Trump was set to nominate vaccine critic Robert F. Kennedy Jr. to head up HHS, which overseas the FDA and CDC.
Trump taps vaccine sceptic Robert F. Kennedy Jnr to lead top US health agency
Kennedy has spread false claims about vaccines, wants fluoride removed from the US water supply and says he’ll gut the FDA.
Trump picks Robert F Kennedy Jr to lead department of health and human services
In a surprising move, U.S. President-elect Donald Trump has tapped environmental activist Robert F. Kennedy Jr. to head the Department of Health and Human Services. Kennedy, known for his controversia...
Trump picks vaccine skeptic RFK Jr. for Health and Human Services secretary
Donald Trump had said that if elected president he would have Robert F. Kennedy Jr. "go wild on health." HHS oversees Medicare, Medicaid, CDC and FDA.
Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium ( 186 Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive R...
Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ: BPMC), a biotech company focused on modulating immune mast cells. In 2023, the FDA approved Blueprint Medicines’ Ayvakit (avap...
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
On Thursday, the FDA granted accelerated approval to PTC Therapeutics, Inc.’s (NASDAQ: PTCT) gene therapy for AADC deficiency, the first-ever gene therapy approved in the U.S. that is directly admini...
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
The U.S. Food and Drug Administration (FDA) has offered positive feedback to CaaMTech, Inc. on its CT-4201 psilocin prodrug program, specifically endorsing the company's approach to addressing "functi...
FDA employees consider how to handle RFK Jr., including leaving
Some staff members at the Food and Drug Administration are considering a quick exit as Robert F. Kennedy Jr.
PTC Therapeutics wins FDA nod for gene therapy
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Thursday, Adial Pharmaceuticals Inc (NASDAQ: ADIL) said it has completed a pharmacokinetics (PK) study of AD04 for Alcohol Use Disorder (AUD) in heavy drinking patients (defined as less than ten drin...
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J. , Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on...
Aldeyra's FDA Resubmission And AbbVie Option Revitalize Reproxalap's Prospects
Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ALDX stock a buy.
Omeros Corporation Reports Third Quarter 2024 Financial Results
– Conference Call Today at 4:30 p.m. ET Omeros Corporation (NASDAQ: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 202...